TP53 structural variants have also been reported in osteosarcoma cell lines [15], rare instances in myeloid leukemia [18, 19] and blast crisis in chronic myelogenous leukemia [20], and in the germline of some families with Li- Fraumeni syndrome [9]. Here, TP53 is linked to myeloid leukemia.